rxstat › Classes › Beta Blocking Agents

Beta Blocking Agents: shortage status in Canada

9 of the 12 beta blocking agents rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Labetalol (Trandate) Widespread shortage 4 of 8 reported products affected Nadolol Widespread shortage 2 of 2 reported products affected Acebutolol (Sectral) Partial shortage 2 of 21 reported products affected Atenolol (Tenormin) Partial shortage 7 of 34 reported products affected Carvedilol Partial shortage 8 of 30 reported products affected · est. return Jul 31, 2026 Metoprolol (Lopresor) Partial shortage 4 of 37 reported products affected · est. return Dec 31, 2026 Pindolol (Visken) Partial shortage 2 of 10 reported products affected Propranolol (Inderal-La) Partial shortage 8 of 17 reported products affected · est. return Aug 10, 2026 Sotalol Partial shortage 3 of 12 reported products affected · est. return Dec 1, 2026 Bisoprolol No current shortage Esmolol (Brevibloc Premixed) No current shortage Nebivolol (Bystolic) No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.